Lindsay J Caverly, MD

 Lindsay Caverly
Clinical Associate Professor of Pediatrics
Medical School
The University of Michigan Medical School
The Department of Pediatrics
1500 E. Medical Center Drive L2221 UH South
Ann Arbor, MI 48109
[email protected]
Available to mentor
Lindsay J Caverly, MD
Lindsay Caverly
Clinical Associate Professor
  • About
  • Links
  • Qualifications
  • Research Overview
  • Recent Publications

  • Manage Your Profile

    • About

    The Caverly lab studies cystic fibrosis airway microbiome and nontube and cystic fibrosis. Dr. Caverly is a board certified Pediatric Pulmonologist at The University of Michigan Medical School.

    Links
    • Michigan Experts
    • PubMed
    • Michigan Medicine Web Profile
    • Lindsay Caverly Lab

    Qualifications
    • Fellowship
      Children's Hospital Colorado, Pediatric Pulmonary, Aurora, United States
      2010 - 2013
      Other
    • Residency
      Children's Hospital Colorado, Pediatrics, Aurora, United States
      2007 - 2010
      Residency
    • MD
      The Ohio State University College of Medicine, Columbus, OH, 43210, United States
      2003 - 2007
    • BA
      Washington University, St Louis, United States
      1998 - 2002

    Research Overview

    Lung Infections in Children with Cystic Fibrosis, with Particular Focus on Atypical Mycobacteria.

    Recent Publications

     See All Publications
    • Journal Article
      Microbiota, Mucus, and Modulators: Cystic Fibrosis Infection Pathogenesis in the Cystic Fibrosis Transmembrane Conductance Regulator Modulator Era
      Thornton CS, Bouzek DC, Caverly LJ. Journal of Infectious Diseases, 2026 Apr 15; 233 (4): 631 - 639. DOI:10.1093/infdis/jiaf626
      PMID: 41406001
    • Journal Article
      Strain-specific persistence of Burkholderia cenocepacia in the C3HeB/FeJ mouse model of pulmonary infection
      Chen Z, Romero-Gonzalez M, Maser A, Leng R, Caverly LJ, Hershenson M, Brunaugh AD. Journal of Medical Microbiology, 2026 Apr 1; 75 (4): DOI:10.1099/jmm.0.002153
      PMID: 41955133
    • Journal Article
      Density fluctuations of Burkholderia and Achromobacter in cystic fibrosis sputum
      Carmody LA, Caverly LJ, Kalikin LM, Thornton CS, Simon RH, VanDevanter DR, LiPuma JJ. Journal of Cystic Fibrosis, 2026 Mar 16; DOI:10.1016/j.jcf.2026.03.006
    • Journal Article
      The EPS-I exopolysaccharide transforms Ralstonia wilt pathogen biofilms into viscoelastic fluids for rapid dissemination in planta
      Cope-Arguello ML, Li J, Konkel Z, Aoun N, Cowell T, Wagner N, Han Chan AL, Chu LT, Wang S, Carter MD, Allen C, Caverly LJ, Bui L, DeAngelis KM, Wargo MJ, Tran TM, Jacobs JM, Manikantan H, Lowe-Power TM. Proceedings of the National Academy of Sciences of the United States of America, 2026 Jan 27; 123 (4): e2512757123 DOI:10.1073/pnas.2512757123
      PMID: 41570073
    • Journal Article
      Investigation of a pseudo-outbreak of Burkholderia cepacia complex caused by contaminated phosphate-buffered saline
      Stone A, Nolt D, Ali R, Kim Y, Caverly LJ, Gold JA, Qin X. American Journal of Infection Control, 2026 Jan 1; DOI:10.1016/j.ajic.2026.01.001
      PMID: 41520924
    • Journal Article
      Physiologically informed in vitro framework reveals context-dependent combinatory activity of niclosamide–colistin against Gram-negative bacteria
      Romero-Gonzalez M, Park M, Lin W, Caverly LJ, Brunaugh AD. Journal of Antimicrobial Chemotherapy, 2025 Nov 1; 80 (11): 2958 - 2969. DOI:10.1093/jac/dkaf323
      PMID: 40919864
    • Presentation
      "Epidemiology of Pseudomonas aeruginosa infection before and after the 2013 Infection Prevention and Control Guidelines", Scientific Symposium Speaker
      Caverly L. 2026 Jun 4;
    • Presentation
      "Lung microbiome and clinical outcomes during antibiotic treatment of cystic fibrosis pulmonary exacerbations: Insights from the STOP2 trial", Scientific Symposium Speaker
      Caverly L. 2026 Jun 4;